Delos Capital
Cambridge, USA · Pre-seed → Growth
Their stated focus (public profile)
Delos Capital is a biotech/life sciences venture capital firm founded in 2014 that invests across all stages in companies advancing medicine, including therapeutics and medtech. The firm focuses on connecting cutting-edge science to well-defined clinical needs across areas such as immunology, oncology, cardiometabolic, rare disease, neurology, and infectious disease. Their portfolio has yielded multiple FDA-approved drugs and device clearances, reflecting a commitment to improving patient health globally.
Stages: Pre-seed → Growth
Sectors: Life sciences, Medtech, Cardiometabolic
On file: 37 companies on record
Website: deloscapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.